Form 8-K - Current report:
SEC Accession No. 0001140361-25-022212
Filing Date
2025-06-11
Accepted
2025-06-11 16:37:01
Documents
13
Period of Report
2025-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20050526_8k.htm   iXBRL 8-K 54697
2 EXHIBIT 10.1 ef20050526_ex10-1.htm EX-10.1 7448
  Complete submission text file 0001140361-25-022212.txt   193732

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20250611.xsd EX-101.SCH 3871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20250611_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20250611_pre.xml EX-101.PRE 16048
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20050526_8k_htm.xml XML 4076
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 251040552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)